Ignite Creation Date:
2024-05-05 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517361
Status:
TERMINATED
Last Update Posted:
2014-04-15
First Post:
2007-08-14
Brief Title:
Phase II Study of Carboplatin and Bevacizumab Avastin for ER Neg PR Neg and HER2Neu Neg Metastatic Breast Cancer
Sponsor:
University of Chicago
Organization:
University of Chicago
Organization Data
Organization:
University of Chicago
Class:
OTHER
Study ID:
15578A
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Chicago
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |